Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May - June - July - August - September - Oktober - November - December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
- 2026
May 2026 - 86 products
Ogsiveo 100 mg
56
k.A.
Coated tablets: Nirogacestatum 100 mg
Merck (Schweiz) AG
A
FB
G
Ogsiveo 150 mg
56
k.A.
Coated tablets: Nirogacestatum 150 mg
Merck (Schweiz) AG
A
FB
G
IP
CI
Ojemda 100 mg
16
k.A.
Coated tablets: Tovorafenibum 100 mg
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
CI
Ojemda 100 mg
20
k.A.
Coated tablets: Tovorafenibum 100 mg
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
CI
Ojemda 100 mg
24
k.A.
Coated tablets: Tovorafenibum 100 mg
Ipsen Pharma Schweiz
GmbH
A
FB
G
Retsevmo 40 mg
56
k.A.
Coated tablets: Selpercatinibum 40 mg
Eli Lilly (Suisse) SA
A
FB
G
Retsevmo 80 mg
56
k.A.
Coated tablets: Selpercatinibum 80 mg
Eli Lilly (Suisse) SA
A
FB
G
IP
Imdylltra 1 mg
k.A.
Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer Infusionslösung: Tarlatamabum 1 mg
Amgen Switzerland AG
A
FB
G
IP
Imdylltra 10 mg
k.A.
Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer Infusionslösung: Tarlatamabum 10 mg
Amgen Switzerland AG
A
FB
G
IP
CI
Ojemda 25 mg/ml
k.A.
Pulver zur Herstellung einer Suspension zum Einnehmen: Tovorafenibum 300 mg
Ipsen Pharma Schweiz
GmbH
A
FB
G
IP
CI
Vyvgart 1000 mg/ 5 ml
k.A.
solution injectable en seringue préremplie: Efgartigimodum Alfa 1000mg / 5ml
argenx Switzerland SA
A
FB
G
IP
CI
Vyvgart 1000 mg/ 5 ml
4
k.A.
solution injectable en seringue préremplie: Efgartigimodum Alfa 1000mg / 5ml
argenx Switzerland SA
A
FB
G
LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml
30
k.A.
Eye drops: 2 Active Agents
OmniVision AG
B
FB
G
LatanoTim-Vision SDU 50 µg / ml + 5 mg / ml
90
k.A.
Eye drops: 2 Active Agents
OmniVision AG
B
FB
G
Gentamicin OrPha 20 mg/2 ml
5
k.A.
Infusion solution: Gentamicinum 20mg / 2ml
OrPha Swiss GmbH
A
FB
G
Gentamicin OrPha 20 mg/2 ml
10
k.A.
Infusion solution: Gentamicinum 20mg / 2ml
OrPha Swiss GmbH
A
FB
G
Gentamicin OrPha 80 mg/2 ml
5
k.A.
Infusion solution: Gentamicinum 80mg / 2ml
OrPha Swiss GmbH
A
FB
G
Gentamicin OrPha 80 mg/2 ml
10
k.A.
Infusion solution: Gentamicinum 80mg / 2ml
OrPha Swiss GmbH
A
FB
G
Labetalol Nardia 5 mg/ml
(100 mg per 20 ml)
5
k.A.
Infusion solution: Labetaloli Hydrochloridum 100mg / 20ml
Nardia
Pharmaceuticals SA
B
FB
G
Liquemin 20'000 I.E. / 48 ml
k.A.
Infusion solution: Heparinum Natricum 417 UI/ml
Drossapharm AG
B
FB
G
Liquemin 20'000 I.E. / 48 ml
5
k.A.
Infusion solution: Heparinum Natricum 417 UI/ml
Drossapharm AG
B
FB
G
Mynzepli 40 mg/ml
k.A.
Injection solution: Afliberceptum 2mg / 0.05ml
Advanz Pharma
Specialty Medicine
Switzerland GmbH
B
FB
G
IP
Byooviz 10 mg / ml
k.A.
Injection solution in prefilled syringe: Ranibizumabum 1.65 mg/ml
Samsung Bioepis CH
GmbH
B
FB
G
Junod 60 mg/ml
k.A.
Injection solution in prefilled syringe: Denosumabum 60 mg
Gedeon Richter
(Schweiz) AG
B
FB
G
Mynzepli 40 mg/ml
k.A.
Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05ml
Advanz Pharma
Specialty Medicine
Switzerland GmbH
B
FB
G
Teizeild 2 mg/2 mL
k.A.
Concentrate for infusion: Teplizumabum 2mg / 2ml
Sanofi-Aventis
(Suisse) SA
A
FB
G
IP
Reblozyl 25 mg
25 mg
k.A.
Dry substance: Luspaterceptum 25 mg
Bristol-Myers Squibb SA
A
FB
G
IP
Reblozyl 75 mg
75 mg
k.A.
Dry substance: Luspaterceptum 75 mg
Bristol-Myers Squibb SA
A
FB
G
Salofalk 1 g
60
k.A.
Suppositories: Mesalazinum 1000 mg
EurimPharm Swiss AG
B
FB
G
Apixax 2.5 mg
20
k.A.
Coated tablets: Apixabanum 2.5 mg
Drossapharm AG
B
FB
G
Apixax 2.5 mg
56
k.A.
Coated tablets: Apixabanum 2.5 mg
Drossapharm AG
B
FB
G
Apixax 2.5 mg
100
k.A.
Coated tablets: Apixabanum 2.5 mg
Drossapharm AG
B
FB
G
Apixax 2.5 mg
168
k.A.
Coated tablets: Apixabanum 2.5 mg
Drossapharm AG
B
FB
G
Apixax 5 mg
56
k.A.
Coated tablets: Apixabanum 5 mg
Drossapharm AG
B
FB
G
Apixax 5 mg
100
k.A.
Coated tablets: Apixabanum 5 mg
Drossapharm AG
B
FB
G
Apixax 5 mg
168
k.A.
Coated tablets: Apixabanum 5 mg
Drossapharm AG
B
FB
G
Imatinib GIST Sandoz 100 mg
60
k.A.
Coated tablets: Imatinibum 100 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Imatinib GIST Sandoz 400 mg
30
k.A.
Coated tablets: Imatinibum 400 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Imatinib Sandoz eco 100 mg
60
k.A.
Coated tablets: Imatinibum 100 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Imatinib Sandoz eco 400 mg
30
k.A.
Coated tablets: Imatinibum 400 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Linagliptin-Mepha 5 mg
30
k.A.
Coated tablets: Linagliptinum 5 mg
Mepha Pharma AG
B
FB
G
Linagliptin-Mepha 5 mg
90
k.A.
Coated tablets: Linagliptinum 5 mg
Mepha Pharma AG
B
FB
G
Linagliptin-Mepha 5 mg
120
k.A.
Coated tablets: Linagliptinum 5 mg
Mepha Pharma AG
B
FB
G
Macitentan Spirig HC 10 mg
30
k.A.
Coated tablets: Macitentanum 10 mg
Spirig HealthCare AG
B
FB
G
Quetiapin NOBEL 25 mg
60
k.A.
Coated tablets: Quetiapinum 25 mg
NOBEL Pharma Schweiz AG
B
FB
G
Quetiapin NOBEL 100 mg
60
k.A.
Coated tablets: Quetiapinum 100 mg
NOBEL Pharma Schweiz AG
B
FB
G
Quetiapin NOBEL 100 mg
105
k.A.
Coated tablets: Quetiapinum 100 mg
NOBEL Pharma Schweiz AG
B
FB
G
Quetiapin NOBEL 200 mg
60
k.A.
Coated tablets: Quetiapinum 200 mg
NOBEL Pharma Schweiz AG
B
FB
G
Quetiapin NOBEL 200 mg
105
k.A.
Coated tablets: Quetiapinum 200 mg
NOBEL Pharma Schweiz AG
B
FB
G
Quetiapin NOBEL 300 mg
60
k.A.
Coated tablets: Quetiapinum 300 mg
NOBEL Pharma Schweiz AG
B
FB
G
Quetiapin NOBEL 300 mg
100
k.A.
Coated tablets: Quetiapinum 300 mg
NOBEL Pharma Schweiz AG
B
FB
G
Sitagliptin Devatis 25 mg
28
k.A.
Coated tablets: Sitagliptinum 25 mg
Devatis AG
B
FB
G
Sitagliptin Devatis 25 mg
98
k.A.
Coated tablets: Sitagliptinum 25 mg
Devatis AG
B
FB
G
Sitagliptin Devatis 50 mg
28
k.A.
Coated tablets: Sitagliptinum 50 mg
Devatis AG
B
FB
G
Sitagliptin Devatis 50 mg
98
k.A.
Coated tablets: Sitagliptinum 50 mg
Devatis AG
B
FB
G
Sitagliptin Devatis 100 mg
28
k.A.
Coated tablets: Sitagliptinum 100 mg
Devatis AG
B
FB
G
Sitagliptin Devatis 100 mg
98
k.A.
Coated tablets: Sitagliptinum 100 mg
Devatis AG
B
FB
G
Tranylcypromine Rivopharm 10 mg
20
k.A.
Coated tablets: Tranylcyprominum 10 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 10 mg
50
k.A.
Coated tablets: Tranylcyprominum 10 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 10 mg
100
k.A.
Coated tablets: Tranylcyprominum 10 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 20 mg
20
k.A.
Coated tablets: Tranylcyprominum 20 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 20 mg
50
k.A.
Coated tablets: Tranylcyprominum 20 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 20 mg
100
k.A.
Coated tablets: Tranylcyprominum 20 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 40 mg
20
k.A.
Coated tablets: Tranylcyprominum 40 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 40 mg
50
k.A.
Coated tablets: Tranylcyprominum 40 mg
Rivopharm SA
B
FB
G
Tranylcypromine Rivopharm 40 mg
100
k.A.
Coated tablets: Tranylcyprominum 40 mg
Rivopharm SA
B
FB
G
Trospium Spirig HC 20 mg
20
k.A.
Coated tablets: Trospii Chloridum 20 mg
Spirig HealthCare AG
B
FB
G
Trospium Spirig HC 20 mg
60
k.A.
Coated tablets: Trospii Chloridum 20 mg
Spirig HealthCare AG
B
FB
G
Valganciclovir Spirig HC 450 mg
60
k.A.
Coated tablets: Valganciclovirum 450 mg
Spirig HealthCare AG
A
FB
G
Pomalidomide PLX
Healthcare Services 1 mg
21
k.A.
Capsules: Pomalidomidum 1 mg
PLX Healthcare
Services (Schweiz)
GmbH
A
FB
G
Pomalidomide PLX
Healthcare Services 2 mg
21
k.A.
Capsules: Pomalidomidum 2 mg
PLX Healthcare
Services (Schweiz)
GmbH
A
FB
G
Pomalidomide PLX
Healthcare Services 3 mg
21
k.A.
Capsules: Pomalidomidum 3 mg
PLX Healthcare
Services (Schweiz)
GmbH
A
FB
G
Pomalidomide PLX
Healthcare Services 4 mg
21
k.A.
Capsules: Pomalidomidum 4 mg
PLX Healthcare
Services (Schweiz)
GmbH
A
FB
G
Ruxolitinib Sandoz 5 mg
56
k.A.
Tablets: Ruxolitinibum 5 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Ruxolitinib Sandoz 5 mg
168
k.A.
Tablets: Ruxolitinibum 5 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Ruxolitinib Sandoz 10 mg
56
k.A.
Tablets: Ruxolitinibum 10 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Ruxolitinib Sandoz 10 mg
168
k.A.
Tablets: Ruxolitinibum 10 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Ruxolitinib Sandoz 15 mg
56
k.A.
Tablets: Ruxolitinibum 15 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Ruxolitinib Sandoz 15 mg
168
k.A.
Tablets: Ruxolitinibum 15 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Ruxolitinib Sandoz 20 mg
56
k.A.
Tablets: Ruxolitinibum 20 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Ruxolitinib Sandoz 20 mg
168
k.A.
Tablets: Ruxolitinibum 20 mg
Sandoz
Pharmaceuticals AG
A
FB
G
Testoviron Depot 250
mg/ml
k.A.
Fertigspritze: Testosteroni Enantas 250 mg/ml
Advanz Pharma
Specialty Medicine
Switzerland GmbH
B
FB
G
IP
CI
Saphnelo 120 mg/0.8 ml
k.A.
Injektionslösung in einem Fertigpen: Anifrolumabum 120mg / 0.8ml
AstraZeneca AG
B
FB
G
IP
CI
Saphnelo 120 mg/0.8 ml
4
k.A.
Injektionslösung in einem Fertigpen: Anifrolumabum 120mg / 0.8ml
AstraZeneca AG
B
FB
G
IP
Vanco Labatec 500 mg
10
k.A.
poudre pour solution à diluer pour perfusion: Vancomycinum 500 mg
Labatec Pharma SA
A
FB
G
IP
Vanco Labatec 1 g
10
k.A.
poudre pour solution à diluer pour perfusion: Vancomycinum 1 g
Labatec Pharma SA
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
